Back to the future of oridonin: again, compound from medicinal herb shows potent antileukemia efficacies in vitro and in vivo
- 10 April 2007
- journal article
- Published by Springer Nature in Cell Research
- Vol. 17 (4), 274-276
- https://doi.org/10.1038/cr.2007.21
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivoBlood, 2006
- Acute promyelocytic leukemia: A model of molecular target based therapyHematology, 2005
- ArtemisininsPostgraduate Medical Journal, 2005
- AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: Implication in stepwise leukemogenesis and response to GleevecProceedings of the National Academy of Sciences, 2005
- Studies on Treatment of Acute Promyelocytic Leukemia With Arsenic Trioxide: Remission Induction, Follow-Up, and Molecular Monitoring in 11 Newly Diagnosed and 47 Relapsed Acute Promyelocytic Leukemia PatientsBlood, 1999
- Rabdosia spp.Published by Springer Nature ,1992
- Cytotoxic and Antitumor Activities ofRabdosiaDiterpenoidsPlanta Medica, 1988
- Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemiaBlood, 1988
- 一种新的抗肿瘤物质——冬凌草素Chinese Science Bulletin, 1978
- Antitumor activity of the isodon diterpenoids: Structural requirements for the activityCellular and Molecular Life Sciences, 1976